Lupkynis Evrópusambandið - íslenska - EMA (European Medicines Agency)

lupkynis

otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - Ónæmisbælandi lyf - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).

Nicotinell Fruit Lyfjatyggigúmmí 2 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

nicotinell fruit lyfjatyggigúmmí 2 mg

haleon denmark aps - nicotinum resin-komplex - lyfjatyggigúmmí - 2 mg

Nicotinell Fruit Lyfjatyggigúmmí 4 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

nicotinell fruit lyfjatyggigúmmí 4 mg

haleon denmark aps - nicotinum resin-komplex - lyfjatyggigúmmí - 4 mg

Kaletra Evrópusambandið - íslenska - EMA (European Medicines Agency)

kaletra

abbvie deutschland gmbh co. kg - lopinavir, rítónavír - hiv sýkingar - antivirals for systemic use, protease inhibitors - kaletra er ætlað ásamt öðrum antiretroviral lyf til meðferð hiv veira (hiv-1) sýkt fullorðnir, unglingum og börn á aldrinum 14 daga og eldri. val á kaletra að meðhöndla próteasahemla upplifað hiv-1 sýkt sjúklingar ætti að vera byggt á einstökum veiru mótstöðu próf og meðferð sögu af sjúklingum.

Skyrizi Evrópusambandið - íslenska - EMA (European Medicines Agency)

skyrizi

abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - Ónæmisbælandi lyf - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.

Zofran Mixtúra, lausn 0,8 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

zofran mixtúra, lausn 0,8 mg/ml

sandoz a/s - ondansetronum hýdróklóríð - mixtúra, lausn - 0,8 mg/ml